Selected article for: "human infection and influenza human infection"

Author: Zhou, Jie; Li, Cun; Sachs, Norman; Chiu, Man Chun; Wong, Bosco Ho-Yin; Chu, Hin; Poon, Vincent Kwok-Man; Wang, Dong; Zhao, Xiaoyu; Wen, Lei; Song, Wenjun; Yuan, Shuofeng; Wong, Kenneth Kak-Yuen; Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Chen, Honglin; Clevers, Hans; Yuen, Kwok-Yung
Title: Differentiated human airway organoids to assess infectivity of emerging influenza virus
  • Document date: 2018_6_26
  • ID: z637eh2z_10
    Snippet: We isolated, plaque-purified, and genotyped these cocirculating viruses. We chose to compare the infectivity of H7N2 with that of H7N9/Ah in the PD organoids as a proof of concept, to verify that the differentiated AOs can indeed simulate human airway epithelium in the context of influenza virus infection. Fig. 4 shows that viral loads in the cell lysate and medium of H7N9/ Ah-infected organoids increased gradually after inoculation; the viral t.....
    Document: We isolated, plaque-purified, and genotyped these cocirculating viruses. We chose to compare the infectivity of H7N2 with that of H7N9/Ah in the PD organoids as a proof of concept, to verify that the differentiated AOs can indeed simulate human airway epithelium in the context of influenza virus infection. Fig. 4 shows that viral loads in the cell lysate and medium of H7N9/ Ah-infected organoids increased gradually after inoculation; the viral titer increased more than 3 log 10 units within 24 h, indicating a robust viral replication. The addition of the serine protease inhibitor AEBSF significantly restricted the active replication of H7N9/Ah virus, highlighting the importance of elevated serine proteases for viral replication. In contrast, H7N2 propagated modestly, with viral titer 2-3 log 10 units lower than H7N9/Ah. Thus, the distinct efficiencies of H7N9/Ah and H7N2 to infect and replicate in the PD AOs can recapitulate the infectivity of these viruses in humans.

    Search related documents:
    Co phrase search for related documents
    • active replication and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active replication and virus infectivity: 1, 2
    • Ah virus and viral replication: 1, 2
    • Ah virus and viral titer: 1
    • Ah virus and virus infectivity: 1, 2
    • cell lysate and viral load: 1, 2, 3, 4
    • cell lysate and viral replication: 1, 2, 3
    • cell lysate and virus infectivity: 1
    • concept proof and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • concept proof and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • concept proof and viral titer: 1, 2, 3
    • concept proof and virus infectivity: 1
    • human airway and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • human airway and viral replication serine protease: 1
    • human airway and viral titer: 1, 2, 3
    • human airway and virus infectivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • human airway epithelium and viral replication: 1, 2, 3, 4, 5, 6, 7, 8
    • human airway epithelium and viral titer: 1
    • human airway epithelium and virus infectivity: 1, 2, 3, 4